tirzepatide shortage ends switching from compounded to zepbound FDA Zepbound ends, impacts patients, compounding pharmacies FDA Says Compounded Tirzepatide Must

1) by selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOI) or other serotonergic agents

What Was Studied

This helps us point you to the right plan Which medication are you on

Regular monitoring of both blood glucose and urinary symptoms provides the most comprehensive picture

A study suggests that peptides like those found in Tirzepatide can degrade or lose potency if not stored under proper conditions, highlighting the importance of refrigeration or temperature control to preserve its efficacy

Tirzepatide is administered once weekly via subcutaneous injection, typically in the abdomen, thigh, or upper arm